Oculus Innovative Sciences Announces Sale of 350,000 Shares of Ruthigen Stock for $962,500 in Non-Dilutive Funding Mar 16, 2015
Oculus Innovative Sciences Announces New Animal Healthcare Division and Launch of MicrocynAH(R) Advanced All-Animal Healthcare Products Feb 26, 2015
Oculus Innovative Sciences Reports Financial Results for the Third Quarter of Fiscal Year 2015 Feb 12, 2015
Oculus Innovative Sciences Announces Fiscal Third Quarter 2015 Financial Results and Conference Call Jan 29, 2015
Oculus Innovative Sciences Announces Closing of $6.3 Million Underwritten Public Offering Jan 26, 2015
Oculus Innovative Sciences Announces Pricing of Upsized $6.3 Million Underwritten Public Offering Jan 21, 2015
Oculus Innovative Sciences Enters Into Agreement to Sell Ruthigen, Inc. Shares for $5.5 Million in Event of Ruthigen Merger Jan 12, 2015
Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2015 Nov 13, 2014
Oculus Innovative Sciences Commercializes Microcyn(R)-Based Solution and Hydrogel for Treatment of Mild-to-Moderate Acne in Europe Nov 11, 2014
